Defining the Putative Inhibitory Site for a Selective Negative Allosteric Modulator of Human 伪4尾2 Neuronal Nicotinic Receptors
详细信息 查看全文
- 作者：Brandon J. Henderson ; Tatiana F. Gonz谩lez-Cestari ; Bitna Yi ; Ryan E. Pavlovicz ; R. Thomas Boyd ; Chenglong Li ; Stephen C. Bergmeier ; Dennis B. McKay
- 刊名：ACS Chemical Neuroscience
- 出版年：2012
- 出版时间：September 19, 2012
- 年：2012
- 卷：3
- 期：9
- 页码：682-692
- 全文大小：486K
- 年卷期：v.3,no.9(September 19, 2012)
- ISSN：1948-7193
文摘
Neuronal nicotinic receptors (nAChRs) have been implicated in several diseases and disorders such as autism spectrum disorders, Alzheimer鈥檚 disease, Parkinson鈥檚 disease, epilepsy, and nicotine addiction. To understand the role of nAChRs in these conditions, it would be beneficial to have selective molecules that target specific nAChRs in vitro and in vivo. Our laboratory has previously identified a novel allosteric site on human 伪4尾2 nAChRs using a series of computational and in vitro approaches. At this site, we have identified negative allosteric modulators that selectively inhibit human 伪4尾2 nAChRs, a subtype implicated in nicotine addiction. This study characterizes the allosteric site via site-directed mutagenesis. Three amino acids (Phe118, Glu60, and Thr58) on the 尾2 subunit were shown to participate in the inhibitory properties of the selective antagonist KAB-18 and provided insights into its antagonism of human 伪4尾2 nAChRs. SAR studies with KAB-18 analogues and various mutant 伪4尾2 nAChRs also provided information concerning how different physiochemical features influence the inhibition of nAChRs through this allosteric site. Together, these studies identify the amino acids that contribute to the selective antagonism of human 伪4尾2 nAChRs at this allosteric site. Finally, these studies define the physiochemical features of ligands that influence interaction with specific amino acids in this allosteric site.